Back to Search
PATRICIA BURCH, PHARMD
PHARMD
Pediatric Pharmacist
NPI: 1942760269Individual
Specialties, Licenses & Credentials
Pediatric PharmacistPrimary
Pharmacist — Pediatrics
Code: 1835P0200X
26027638A(IN)
Research & Publications (20)
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
PMID 15803016·Am J Clin Oncol·2005
3-trial
An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.
PMID 15143165·Mol Cell Biol·2004
7-preclinical
Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.
PMID 15176049·Prostate·2004
3-trial
Mortality in murine peritonitis correlates with increased Escherichia coli adherence to the intestinal mucosa.
PMID 15098788·Am Surg·2004
4-observational
Phase II study of paclitaxel and cisplatin for advanced urothelial cancer.
PMID 11025699·J Urol·2000
3-trial
A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas.
PMID 10958598·Invest New Drugs·2000
3-trial
Phase II evaluation of continuous-infusion 5-fluorouracil, leucovorin, mitomycin-C, and oral dipyridamole in advanced measurable pancreatic cancer: a North Central Cancer Treatment Group Trial.
PMID 11039519·Am J Clin Oncol·2000
3-trial
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.
PMID 10873066·Clin Cancer Res·2000
3-trial
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study.
PMID 10999733·Clin Cancer Res·2000
3-trial
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
PMID 19536890·Cancer·2009
3-trial
Stentless porcine valves in the right ventricular outflow tract: improved durability?
PMID 19211257·Eur J Cardiothorac Surg·2009
7-preclinical
Mobile phones in hospital. Resurgence in memorial postmortem photography?
PMID 19293207·BMJ·2009
8-other
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
PMID 19380444·J Clin Oncol·2009
3-trial
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
PMID 17320666·Urology·2007
3-trial
Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
PMID 17932892·Cancer·2007
8-other
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
PMID 16502355·Invest New Drugs·2006
3-trial
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
PMID 16622120·J Natl Cancer Inst·2006
8-other
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
PMID 16782921·J Clin Oncol·2006
2-rct
SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth.
PMID 17015617·J Cell Biol·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2001 W 86TH ST, PHARMACY DEPARTMENT
INDIANAPOLIS, IN 46260 - Phone
- (317) 338-8050
Quick Facts
- NPI
- 1942760269
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile